Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)
Karen Sliwa(University of Cape Town), Johann Bauersachs(Medizinische Hochschule Hannover), Mark C. Petrie(British Heart Foundation), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Piotr Ponikowski(Wroclaw Medical University), Luigi Tavazzi(Maria Cecilia Hospital), Amam Mbakwem(University of Lagos), Vera Regitz‐Zagrosek(Charité - Universitätsmedizin Berlin), Maria Schaufelberger(Apple (Israel)), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Petar Seferović, Frédéric Mouquet(Centre Hospitalier Universitaire de Lille), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Aldo P. Maggioni(Health Care Foundation), Karin van Spandonck‐Zwarts(Amsterdam UMC Location University of Amsterdam), Peter van der Meer(University Medical Center Groningen), Cécile Laroche(European Society of Cardiology), Jolien W. Roos‐Hesselink(Erasmus MC), Roger Hall(University of East Anglia), Michael Böhm(Saarland University)
Cited by 232
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k